Baillie Gifford & Co’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-121,855
| Closed | -$992K | – | 276 |
|
|
2024
Q3 | $992K | Sell |
121,855
-308,742
| -72% | -$2.51M | ﹤0.01% | 254 |
|
|
2024
Q2 | $2.75M | Sell |
430,597
-106,171
| -20% | -$678K | ﹤0.01% | 239 |
|
|
2024
Q1 | $4.04M | Sell |
536,768
-1,550
| -0.3% | -$11.7K | ﹤0.01% | 242 |
|
|
2023
Q4 | $4.98M | Sell |
538,318
-28,818
| -5% | -$267K | ﹤0.01% | 239 |
|
|
2023
Q3 | $5.74M | Sell |
567,136
-23,318
| -4% | -$236K | 0.01% | 231 |
|
|
2023
Q2 | $7.38M | Sell |
590,454
-11,309
| -2% | -$141K | 0.01% | 229 |
|
|
2023
Q1 | $7.02M | Buy |
601,763
+2,851
| +0.5% | +$33.3K | 0.01% | 234 |
|
|
2022
Q4 | $6.37M | Buy |
598,912
+192,959
| +48% | +$2.05M | 0.01% | 238 |
|
|
2022
Q3 | $3.94M | Buy |
405,953
+13,436
| +3% | +$130K | ﹤0.01% | 247 |
|
|
2022
Q2 | $5.69M | Sell |
392,517
-47,650
| -11% | -$691K | 0.01% | 228 |
|
|
2022
Q1 | $11.5M | Buy |
440,167
+41,788
| +10% | +$1.09M | 0.01% | 230 |
|
|
2021
Q4 | $15.8M | Buy |
398,379
+17,376
| +5% | +$688K | 0.01% | 230 |
|
|
2021
Q3 | $19.1M | Buy |
381,003
+81,441
| +27% | +$4.07M | 0.01% | 227 |
|
|
2021
Q2 | $16.6M | Buy |
299,562
+36,732
| +14% | +$2.04M | 0.01% | 234 |
|
|
2021
Q1 | $12.3M | Buy |
262,830
+140,777
| +115% | +$6.58M | 0.01% | 237 |
|
|
2020
Q4 | $5.31M | Buy |
122,053
+59,738
| +96% | +$2.6M | ﹤0.01% | 231 |
|
|
2020
Q3 | $2.28M | Buy |
62,315
+56,328
| +941% | +$2.06M | ﹤0.01% | 229 |
|
|
2020
Q2 | $175K | Buy |
5,987
+2,635
| +79% | +$77K | ﹤0.01% | 238 |
|
|
2020
Q1 | $88K | Buy |
3,352
+860
| +35% | +$22.6K | ﹤0.01% | 219 |
|
|
2019
Q4 | $86K | Hold |
2,492
| – | – | ﹤0.01% | 220 |
|
|
2019
Q3 | $79K | Buy |
+2,492
| New | +$79K | ﹤0.01% | 220 |
|